News
01.07.2024
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
28.06.2024
CEMM: New Adapter Molecule Expands Therapeutic Potential Around the Cell's Waste Disposal System
27.06.2024
University of Vienna: Long-standing marine mystery solved: How algae get nitrogen to grow
27.06.2024
Angels United: “All Stars” Business Angel-Konsortium plant über 30 Startup-Investments
27.06.2024
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board
26.06.2024
Österreichischer Generikaverband: Sichere Arzneimittelversorgung nur mit Generika möglich
25.06.2024
MedUni Vienna: Psychoactive agents in psychotherapy: New MDMA variants identified for potentially safer use
24.06.2024
Novartis eröffnet CC2Plus und komplettiert schnellste Zellkultur-Anlage im Novartis-Netzwerk
24.06.2024
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®